This review critically evaluates the current role of single photon emi
ssion tomography (SPET) imaging in the clinical management of patients
with dementia. The classification of the dementias is discussed and t
he clinical and pathological features of the various dementing illness
es are described. Typical appearances on cerebral blood flow imaging a
re presented for each of the conditions, together with the findings on
D-2 dopaminergic receptor and muscarinic receptor imaging where this
is relevant. The review concludes with a section on the clinical value
of SPET imaging in dementia. SPET imaging can make a valuable contrib
ution to the accurate clinical differentiation of dementia, providing
findings are interpreted in the light of neurological evaluation and s
tructural imaging. The possible future role of SPET imaging in the pre
diction and evaluation of response to future therapeutic agents is dis
cussed.